Pulmonary Delivery and Inhalation Dosage Forms Quiz
22 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What are the primary differences between CFCs and HFCs in Metered Dose Inhalers (MDIs)?

  • CFCs have higher vapour pressures and are poorer solvents than HFCs. (correct)
  • CFCs have lower vapour pressures and are better solvents than HFCs.
  • CFCs and HFCs have the same vapour pressures and solvency properties.
  • CFCs and HFCs have opposite vapour pressures and solvency properties.
  • Which type of inhaler uses mechanical energy derived from a spring to generate a metered dose?

  • Hydrofluorocarbons (HFCs) based inhalers.
  • Spring-Mechanical Inhalers (SMIs). (correct)
  • Soft Mist™ Inhalers.
  • Chlorofluorocarbons (CFCs) based inhalers.
  • Which inhaler device is designed to accommodate patients who cannot use traditional inhalers, such as young children and severely ill patients?

  • Respimat® Soft Mist™ Inhaler.
  • Jet Nebulizer.
  • Inhalation Nebulizer.
  • Ultrasonic Nebulizer. (correct)
  • Which type of inhaler has a dose and particle size distribution that is independent of the variable inspiratory flow of the patient?

    <p>Spring-Mechanical Inhalers (SMIs).</p> Signup and view all the answers

    What type of energy is used to generate a metered dose in Soft Mist™ Inhalers?

    <p>Pressurized gas energy.</p> Signup and view all the answers

    What are the primary formulations used in nebulizers?

    <p>Solutions or suspensions.</p> Signup and view all the answers

    What is one of the features of the lungs that can facilitate systemic delivery of drugs?

    <p>Thinness of the alveolar epithelium</p> Signup and view all the answers

    In the context of pulmonary delivery, what does CSA:ASA ratio of 0.88 indicate?

    <p>Good capacity for solute exchange</p> Signup and view all the answers

    Why is pulmonary delivery suitable for non-respiratory diseases like proteins and peptides?

    <p>Technically impossible oral administration</p> Signup and view all the answers

    What is a key advantage of targeted delivery to the lungs?

    <p>High bioavailability</p> Signup and view all the answers

    In the context of EXUBERA, what was a challenge related to dose description inconsistency?

    <p>3mg pack delivering 3 units of insulin</p> Signup and view all the answers

    Why did patients using EXUBERA still need subcutaneous injections of longer-acting insulin?

    <p>To maintain base insulin levels</p> Signup and view all the answers

    What was the primary reason for Exubera's poor sales performance?

    <p>The cost was too high</p> Signup and view all the answers

    Which of the following is not a disadvantage of Exubera?

    <p>The lack of effectiveness in treating basal insulin doses</p> Signup and view all the answers

    Which of the following is a possible reason for the poor sales of Exubera apart from its high cost?

    <p>All of the above</p> Signup and view all the answers

    What was the primary reason for Pfizer's decision to 'write off' Exubera?

    <p>The poor sales figures</p> Signup and view all the answers

    Which of the following best describes the deposition mechanisms of inhaled particles in the respiratory tract?

    <p>Impaction, Sedimentation, Diffusion, Electrostatic Precipitation</p> Signup and view all the answers

    Which of the following is not a factor affecting lung deposition mechanisms in patients?

    <p>The size of the inhalation device</p> Signup and view all the answers

    Which of the following is not a type of inhalation system?

    <p>Electrostatic Precipitators</p> Signup and view all the answers

    Which of the following is not a property of Technosphere® particles?

    <p>They are made from the crystalline form of human insulin</p> Signup and view all the answers

    Which of the following is not a possible reason for the poor sales of MannKind's Pulmonary Insulin?

    <p>The poor performance of the product</p> Signup and view all the answers

    Which of the following is not a factor affecting the deposition of particles in the human lung?

    <p>Particle concentration</p> Signup and view all the answers

    Study Notes

    Metered Dose Inhalers (MDIs)

    • MDIs incorporate a propellant under pressure to generate a metered dose of an aerosol through an atomization nozzle.
    • MDIs use chlorofluorocarbons (CFCs) or hydrofluorocarbons (HFCs) as propellants.
    • CFCs were banned due to their contribution to ozone layer depletion, and HFCs have higher vapor pressures and poorer solvency.

    Developments in MDIs

    • Spring-mediated inhalers (SMIs) use mechanical energy to force a drug solution through a nozzle, producing a dose-independent aerosol.
    • Respimat Soft Mist Inhaler is an example of an SMI.

    Nebulizers

    • Nebulizers are atomizers that produce a high concentration of droplets from liquids.
    • They use a compressor and pump to deliver a fine mist of medication.
    • Nebulizers are suitable for people who cannot use inhalers, such as young children and those who are very ill.

    Advances in Nanomedicine

    • Few examples of drugs and polymeric carriers are available for pulmonary delivery.

    Pulmonary Delivery

    • The lungs have a large surface area, good vascularization, and immense capacity for solute exchange, making them suitable for systemic delivery.
    • Inhalation allows for targeted delivery, rapid absorption, and absence of first-pass metabolism.

    Inhalation Dosage Forms

    • Inhalation dosage forms have been used for over 4000 years.
    • The lungs have a large surface area, thin alveolar epithelium, and good vascularization, making them suitable for systemic delivery.

    Exubera

    • Exubera is an inhaled insulin product that delivers insulin through oral inhalation.
    • It was withdrawn from the market due to poor sales figures.
    • The product had several disadvantages, including the need for patients to still use subcutaneous insulin, inconvenient inhalation device, and confusing dose equivalence.

    Lung Deposition Mechanisms

    • Mechanisms of deposition include impaction, interception, sedimentation, diffusion, and electrostatic precipitation.
    • Particle size affects total deposition of particles in the human lung.

    Devices

    • Dry Powder Inhalers (DPIs) are breath-actuated and use the patient's inhalation to disperse and generate the aerosol.
    • DPIs require supporting data on dose consistency and flow rate independence.
    • Metered Dose Inhalers (MDIs) and nebulizers are other types of inhalation devices.

    Development of Formulation and Devices

    • The development of formulations and devices involves high complexity and complexity.
    • Particle engineering, particle size distribution, and drug-carrier interactions are important factors in DPI development.

    Technosphere Particles

    • Technosphere particles are used in DPIs, such as the MedTone inhaler with a single-use cartridge containing Technosphere/Insulin powder (AFREZZA).
    • FDKP (fumaryl diketo piperazine) is a white solid with a molecular weight of 452 Daltons that is highly soluble in water at neutral-basic pH.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on pulmonary delivery and inhalation dosage forms, exploring the features of the lungs that facilitate systemic delivery, such as large surface area, good vascularization, and thinness of the alveolar epithelium. Understand why inhalation allows for direct delivery to the lungs with reduced systemic side effects.

    More Like This

    Use Quizgecko on...
    Browser
    Browser